Brain-Computer interface aims to stop epileptic seizures before they start

NCT ID NCT06898138

Not yet recruiting Knowledge-focused Sponsor: Mayo Clinic Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early study at Mayo Clinic tests a new implantable device called the Brain Interchange System in up to 8 people with drug-resistant epilepsy. The device records high-speed brain signals and can deliver targeted electrical stimulation to prevent seizures. Unlike current systems that react after a seizure starts, this one aims to detect warning signals and stop seizures before they happen. For now, the study only checks if the device works as intended, not whether it actually controls seizures.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

CorTec Brain Interchange System (implantable device for sensing and stimulation)

What this could lead to

If successful, this could pave the way for a future implant that stops seizures before they start, improving seizure control for people with drug-resistant epilepsy.

What could go wrong

This is a very early feasibility study with only 8 participants. It tests whether the device can detect and respond to brain signals, not whether it actually stops seizures. Many technical hurdles remain.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPILEPSY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

epilepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Baylor College of Medicine

    Houston, Texas, 77030-3498, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Mayo Clinic

    Rochester, Minnesota, 55905, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••